ENTRY       D10390                      Drug
NAME        Pidilizumab (USAN/INN)
FORMULA     C6424H9920N1704O2002S48
EXACT_MASS  144503.3409
MOL_WEIGHT  144592.8372
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Anti-PD-1 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of cancer and infectious diseases
TARGET      PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
  PATHWAY   hsa04514(5133)  Cell adhesion molecules
            hsa04660(5133)  T cell receptor signaling pathway
            hsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D10390  Pidilizumab
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                PDCD1 (PD1, CD279)
                 D10390  Pidilizumab (USAN/INN)
DBLINKS     CAS: 1036730-42-3
            PubChem: 172232483
///
